Rolf M Huseby

Login / Register
$2.5B in R&D Funding for US Small Business

You are viewing an R&D grant awarded to a high-tech startup. The SBIR database contains more than 150,000 such awards as well as company and personnel profiles for the top researchers in virtually every emerging technology area.
- Find Out More
Close

Award Title	Agency	Phase	Award amount	Start Date	End Date
ApoFasL: a Novel Immunotherapeutic for T1D Apoimmune, Inc. Principal Investigator	HHS	1	$422K	08/06/07	01/31/09
Chimeric CD80-SA as a Novel Cancer Vaccine Apoimmune, Inc. Principal Investigator	HHS	1	$417K	09/01/06	08/31/07
Chimeric CD80-SA as a Novel Cancer Vaccine Apoimmune, Inc. Principal Investigator	HHS	1	$352K	09/27/05	08/31/06